Geavlete P, Niţă Gh, Geavlete B
Department of Urology, "Saint John" Emergency Clinical Hospital, Bucharest, Romania.
J Med Life. 2008 Oct-Dec;1(4):454-60.
Potassium-titanyl-phosphate (KTP) laser photoselective vaporization prostatectomy (PVP) is a relatively new technology for the management of benign prostatic hyperplasia (BPH). We reviewed our initial experience regarding the efficacy and safety of this technique for symptomatic and obstructive BPH.
During the last year, 35 patients with a mean age of 65.3 years (between 53 and 80) and symptomatic BPH were treated by laser prostatectomy using KTP/532 laser energy at 120W. The procedure was performed through a 21F continuous-flow cystoscope with normal saline as irrigant. All patients underwent standard urologic evaluation using the International Prostate Symptom Score (LPSS), the urinary peak flow rate (Q(max)), ultrasound measurement of prostate volume and residual urine volume, assay of prostate specific antigen (PSA) and digital rectal examination (DRE). The mean prostatic volume was 45 cm3 (range 30-70 cm3). The patients were reassessed postoperatively at 3 and 6 months.
In all cases, KTP laser vaporization was successfully performed, with a mean operating time of 57 minutes (range 20-120 minutes). In most cases, we used just one fibre, the mean energy released being 170.000 Joules (range 80.000-270.000). The mean hospital stay was 24 hours. No major complications occurred intraoperatively or postoperatively, and no transfusions were necessary. All patients were catheter-free after 1 month. At 3 and 6 months, the mean urinary peak flow increased from the preoperative value of 8.5 mL/sec to 23.7 mL/sec and 21.2 mL/sec, respectively. The mean IPSS decreased from 19.0 to 9.5 and 7.5 at 3 and 6 months, and the mean post-voiding residual volume (PVR) decreased from 90.5 to 30.5 mL and 15.0 mL. Two patients were admitted for secondary hematuria and urinary infection, and 7 patients presented irritative low urinary tract symptoms during their first postoperative check-up.
BPH photoselective vaporization using 120W Green Light laser is a safe and easy to learn technique, with good functional results and a low rate of complications.
磷酸钛氧钾(KTP)激光选择性前列腺汽化切除术(PVP)是一种用于治疗良性前列腺增生(BPH)的相对较新的技术。我们回顾了我们关于该技术治疗有症状和梗阻性BPH的疗效及安全性的初步经验。
在过去一年中,35例平均年龄65.3岁(53至80岁)且有症状的BPH患者接受了使用120W KTP/532激光能量的激光前列腺切除术。手术通过21F连续流膀胱镜进行,使用生理盐水作为灌洗液。所有患者均接受了标准的泌尿外科评估,包括国际前列腺症状评分(IPSS)、尿流率峰值(Q(max))、前列腺体积及残余尿量的超声测量、前列腺特异性抗原(PSA)检测以及直肠指检(DRE)。平均前列腺体积为45 cm³(范围30 - 70 cm³)。患者在术后3个月和6个月进行复查。
所有病例均成功进行了KTP激光汽化,平均手术时间为57分钟(范围20 - 120分钟)。大多数情况下,我们仅使用一根光纤,平均释放能量为170,000焦耳(范围80,000 - 270,000)。平均住院时间为24小时。术中及术后均未发生重大并发症,无需输血。所有患者在1个月后均拔除了导尿管。在3个月和6个月时,尿流率峰值分别从术前的8.5 mL/秒增加至23.7 mL/秒和21.2 mL/秒。平均IPSS在3个月和6个月时分别从术前的19.0降至9.5和7.5,平均排尿后残余尿量(PVR)从90.5 mL降至30.5 mL和15.0 mL。2例患者因继发性血尿和尿路感染入院,7例患者在术后首次检查时出现刺激性下尿路症状。
使用120W绿光激光进行BPH选择性汽化是一种安全且易于掌握的技术,具有良好的功能效果和较低的并发症发生率。